Clinical Nephrology – Epidemiology – Clinical TrialsSafety of losartan in hypertensive patients with thiazide-induced hyperuricemia
Under an Elsevier user license
open archive
Keywords
hypertension
angiotensin II receptor antagonist
uric acid
acute urate nephropathy
crystal formation
Cited by (0)
- 1
Losartan Uric Acid Study Group: Frederic Coe and Jason Umans (University of Chicago, Chicago IL, USA), Charles Kaupke (University of California Irvine Medical Center, Orange, CA, USA), Barton Levine (VA Medical Center, West Los Angeles, Los Angeles, CA, USA), Thomas Marbury (Orlando Clinical Research Center, Orlando, FL, USA), F.G. McMahon (Clinical Research Center, New Orleans, LA, USA), Michael Smith (University Hospitals of Cleveland, Cleveland, OH, USA), and Suzanne Swan (Hennepin County Medical Center, Minneapolis, MN, USA).
Copyright © 1999 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.